AFC-HD AMS Life Science Full Year 2024 Earnings: EPS: JP¥88.62 (vs JP¥78.47 in FY 2023)

Simply Wall St · 10/18 22:18

AFC-HD AMS Life Science (TSE:2927) Full Year 2024 Results

Key Financial Results

  • Revenue: JP¥30.2b (up 18% from FY 2023).
  • Net income: JP¥1.24b (up 13% from FY 2023).
  • Profit margin: 4.1% (down from 4.3% in FY 2023). The decrease in margin was driven by higher expenses.
  • EPS: JP¥88.62 (up from JP¥78.47 in FY 2023).
earnings-and-revenue-history
TSE:2927 Earnings and Revenue History October 18th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

AFC-HD AMS Life Science shares are up 2.3% from a week ago.

Risk Analysis

We should say that we've discovered 3 warning signs for AFC-HD AMS Life Science (1 is a bit concerning!) that you should be aware of before investing here.